Global HIV/AIDS Testing Industry

Mar 14, 2016, 21:44 ET from Reportlinker

NEW YORK, March 14, 2016 /PRNewswire/ -- This report analyzes the worldwide markets for HIV/AIDS Testing in Thousands (volume) and US$ Thousand (value) by the following Product Segments: HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 42 companies including many key and niche players such as -

Abbott Laboratories, Inc.
Adaltis S.r.l.
Alere
Beckman Coulter, Inc.
bioMérieux SA



Read the full report: http://www.reportlinker.com/p03449664-summary/view-report.html



I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1 Disclaimers.............. I-2 Data Interpretation & Reporting Level I-2 Quantitative Techniques & Analytics I-2 Product Definitions and Scope of Study I-3 Definitions.............. I-3 HIV/AIDS Screening Tests..............I-3 HIV/AIDS Confirmatory Tests..............I-3 HIV/AIDS Monitoring Tests..............I-3

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW.............. II-1 Worldwide HIV/AIDS Testing Market - An Analysis II-1 Regional Analysis..............II-2 Segment Analysis.............. II-3 HIV/AIDS Screening Tests..............II-3 HIV/AIDS Confirmatory Tests..............II-3 HIV/AIDS Monitoring Market..............II-3 Competition.............. II-4 HIV/AIDS Diagnostics Market Participants - Product Matrix II-4 FDA/USAID Approved HIV Rapid Test Kits (2014) II-6 FDA-Approved Anti-HIV-1/2 and HIV-1 Antigen Combo Assays II-7

2. GROWTH DRIVERS AND MARKET TRENDS..............II-8 Rapid HIV Tests - Vast Growth Potential II-8 Rapid Screening Tests Prevent Epidemic Spread II-8 New HIV Assays to Fuel Growth..............II-9 Trends in Viral Load Testing..............II-9 Table 1: Viral Load Volumes by Region: Percentage Share of Viral Load Test Volumes for South Africa, Sub-Saharan Africa, and Rest of World (2015, 2017E, & 2019E) (includes corresponding Graph/Chart)..............II-9

Table 2: Viral Load Testing Potential by Setting: Percentage Share of Viral Load Test Volumes for District Hospitals, Large Urban Clinics, and Small Rural Clinics (2015, 2018E, & 2020E) (includes corresponding Graph/Chart) II-10 Home Testing or Self-Testing to Gain Strength II-10 Self Testing: WHO Initiatives II-10 Challenges Involved in Self-Testing II-11 DNA-PCR: Preferred Technique for Early Infant Diagnosis (EID) II-12 Commercial HIV Vaccines in the Pipeline II-12 List of Clinical Trial (Phase II) AIDS Vaccines - 2015 II-13 Molecular Diagnostics Register Strong Growth in Blood Screening Markets..............II-13 Emergency Room Testing to Help HIV Diagnosis II-13 OTC Tests Provide Momentum to HIV Testing II-13

3. HIV/AIDS STATISTICS..............II-14 AIDS: A Global Epidemic..............II-14 Facts & Figures.............. II-14 Table 3: HIV Infection Statistics Worldwide: As of 2014 (includes corresponding Graph/Chart) II-15

Table 4: Worldwide HIV Prevalence and Incidence (in Million) by Region: 2014 (includes corresponding Graph/Chart) II-15

Table 5: Worldwide AIDS related Deaths by Geographic Region: 2014 (includes corresponding Graph/Chart) II-16

Table 6: HIV Prevalence (%) in Adults (15-49 years) by Year: Prevalence Percentage in Adults in 1990, 2000, 2008 & 2014 (includes corresponding Graph/Chart) II-16

Table 7: HIV Testing Service Penetration, by Region (2010-2014): Percentage Share of Adults who received HIV Testing Services in Various Global Regions (includes corresponding Graph/Chart)..............II-17

Table 8: HIV Testing Services Availed, by Gender (2014): Percentage Breakdown of Women and Men in all WHO Regions (includes corresponding Graph/Chart) II-17

Table 9: HIV-Positive Individuals, by Gender (2014): Percentage Breakdown of Women and Men Tested HIV-Positive in all WHO Regions (includes corresponding Graph/Chart) II-17

Table 10: International & Domestic Spending on ART in Low/Middle-Income Countries, by Region (2013): Expenditure in Millions up to 2013 (includes corresponding Graph/Chart) II-18

Table 11: No. of People on Antiviral therapy in Low/Middle-Income Countries, by Region: Numbers in 2012, 2013 & 2014 (includes corresponding Graph/Chart) II-19 Anti-AIDS Therapeutics: A Blessing in Disguise in Developed Countries.............. II-19

4. HIV/AIDS: UNDERSTANDING THE DISEASE II-20 Mechanism of Action.............. II-20 Symptoms.............. II-21 Full-Blown AIDS.............. II-22 Transmission of HIV.............. II-22 On the Brighter Side..............II-23 HIV Therapy.............. II-23 The Search Continues..............II-23 Infection Process - Targets for HIV Therapy II-24

5. DIAGNOSIS OF HIV/AIDS..............II-25 Testing: The Basis for AIDS Prevention and Treatment II-25 Blood Processing.............. II-25 The Earliest Time to Detect Infection II-25 Problems Plaguing HIV Testing..............II-26 Major Drawbacks of Laboratory Diagnosis of HIV Infections II-26 Rapid Tests - SuiTable for Developing Countries II-26 HIV Tests.............. II-27 Testing Subject to Strict Rules II-27 Diagnostic Tests.............. II-27 I. Antibody Tests.............. II-27 A. HIV-1 Screening Tests..............II-27 Test Methodology..............II-28 a. Enzyme-linked Immunosorbent Assays/ Enzyme Immunoassays (ELISA/EIA) II-28 b. Home Access HIV-1 test system/Dried Blood Spot II-29 c. Rapid Tests.............. II-30 B. HIV-1 Antibody Confirmatory Tests II-31 a. The Western Blot Test..............II-31 Commonly Used in Developed Countries II-32 Interpretation of Results..............II-32 Modified Western Blots..............II-33 b. Indirect Immunofluorescent Antibody Assay (IFA) II-33 c. Line Immunoassay..............II-33 d. Radioimmunoprecipitation Assay (RIPA) II-33 C. HIV-2 Diagnostic Tests and HIV Group "O II-33 Testing Protocols..............II-34 Types of Antibody Tests Based on Sample II-35 i. Traditional Blood Antibody Tests II-35 ii. Dried Blood Spot (DBS) Sampling Technique II-35

iii. Other Alternatives in Samples II-35 Oral Testing for HIV..............II-35 Urine Tests..............II-36 II. Viral Identification Assays II-36 A. p24 Antigen Test..............II-36 B. Qualitative PCR Tests..............II-36 PCR: The Process..............II-37 C. Viral Culture.............. II-37 III. Monitoring Tests..............II-37 A. Lymphocyte Analysis..............II-37 CD4 Cell Counts..............II-37 B. Viral Load Tests..............II-38 Indicator of Successful Therapy II-38 Levels of CD4 and Viral Load in AIDS II-39 Molecular Diagnostics and Gene Detection Products II-39 DNA Probe-Based Products..............II-39 Direct Assays.............. II-39 Amplification.............. II-39 Amplification Methodologies..............II-40 DNA Chips.............. II-40 Growth of DNA Chips Influenced by HIV Research II-40 Technology Review.............. II-40 Home HIV Tests: Unfolding a New Era of Testing II-40 PCR: A Promising Development in HIV/AIDS Monitoring Market II-41 DNA Probes are Highly Specific and Sensitive II-41 OCA-particles Based Detection System-Offers Increased Accuracy II-41 Drawbacks of Blood-Based Tests II-42 Regulations.............. II-42 Regulatory Overview..............II-42 UN's Testing Policies in Peacekeeping Force II-42 Anonymous versus Confidential Diagnostic Testing for HIV infection in US.............. II-43 Regulatory Approval for Rapid HIV Test Kits in US II-43 HIV Testing - Mandatory in US Blood Banks II-43

6. PRODUCT APPROVALS & LAUNCHES..............II-44 BioPlex® 2200 HIV Ag-Ab Assay Receives FDA Pre-market Approval II-44 Beckman Coulter Obtains CE Marking for DxN VERIS HIV-1 Assay II-44 Chembio Receives CE Mark Approval for its DPP® HIV 1/2 Assay II-44 BioSure UK Launches HIV Home Testing Kit II-44 USFDA Approves cobas® TaqScreen MPX Test by Roche Diagnostics II-44 Xpert® HIV-1 Viral Load Test Acquires CE-IVD Status II-44 Hologic Announces CE Mark Certification for its Aptima HIV-1 Quant Dx Assay.............. II-45 Bio-Rad's Geenius™ HIV 1/2 Supplemental Assay Receives USFDA Pre-market Approval..............II-45 LabCorp Launches HIV GenoSure ArchiveSM Test to Optimize Drug Regimens.............. II-45 DiaSorin Launches Liaison XL Murex HIV Ab/Ag High Throughput Test II-45 Bio-Rad Launches BioPlex 2200 HIV Ag-Ab Kit for Ex-US Markets II-45 MedMira Receives Approval to Market Enhanced Version of Reveal HIV Test in Europe.............. II-45 Roche Receives CE Certification to Launch Dual target COBAS Test II-45 Theradig and CNRS to Develop Theranostics HIV/AIDS Tests II-46 LabCorp Introduces HIV Ag/Ab Combination Assay and Screening Algorithm.............. II-46 Alere Launches Rapid POC Determine HIV ½ Ag/Ag Combo Test II-46

7. RECENT INDUSTRY ACTIVITY..............II-47 DiaSorin and Beckman Coulter Sign Distribution Partnership Agreement.............. II-47 Global Initiative Lowers Price of Infant Early HIV Diagnostic Technologies.............. II-47 USAID Project to Deliver HIV Testing Services in Africa II-47 Roche to Provide HIV-1 Viral Load and Early Infant Diagnostic Technologies for Global Fund..............II-47 Bio-Rad and Beckman Coulter Extend Distribution Agreement II-47 Case Western Reserve University Hospital Signs Agreement with Advanced Biological Laboratories II-47 UNAIDS Collaborates with Global Partners to Launch Diagnostics Access Initiative..............II-48 Zyomyx Acquires $7.5 M from WHO to Market MyT4 CD4 Test in Developing World.............. II-48 Daktari Diagnostics Seeks Funding for HIV Test Manufacturing Capacity.............. II-48 Gilead Sciences and Good Samaritan Foundation Enter Into Partnership to Provide HIV Testing in Africa II-48 Chembio Signs Technology License, Distribution & Manufacturing Agreements with RVR Diagnostics SDN BHD II-48 Mylan Signs Exclusive Distribution Agreement with Zyomyx for POC CD4 Test.............. II-48 Calypte Biomedical and Maxim Sign Joint Distribution Agreement for HIV Tests.............. II-48

8. FOCUS ON SELECT GLOBAL PLAYERS..............II-49 Abbott Laboratories, Inc. (US) II-49 Abbott Molecular, Inc. (US)..............II-49 Adaltis S.r.l. (Italy)..............II-49 Alere (US).............. II-50 Beckman Coulter, Inc. (US)..............II-50 bioMérieux SA (France)..............II-50 Bio-Rad Laboratories, Inc. (US)..............II-50 Calypte Biomedical Corporation (US) II-51 Chembio Diagnostic Systems, Inc. (US) II-51 Hologic, Inc. (US)..............II-52 Fujirebio Europe N.V. (Belgium)..............II-52 MedMira Inc. (Canada)..............II-52 OraSure Technologies, Inc. (US)..............II-53 Ortho-Clinical Diagnostics, Inc. (US) II-53 Quest Diagnostics, Inc. (US)..............II-53 Roche Diagnostics (Switzerland)..............II-54 Siemens Healthcare Diagnostics, Inc. (US) II-54 Trinity Biotech Plc. (Ireland) II-55

9. GLOBAL MARKET PERSPECTIVE..............II-56 Unit Analytics.............. II-56 Table 12: World Recent Past, Current & Future Analysis for HIV/AIDS Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart) II-56

Table 13: World Historic Review for HIV/AIDS Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart).............. II-57

Table 14: World 14-Year Perspective for HIV/AIDS Testing by Geographic Region - Percentage Breakdown of Unit Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart) II-58

Table 15: World Recent Past, Current & Future Analysis for HIV/AIDS Screening Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart) II-59

Table 16: World Historic Review for HIV/AIDS Screening Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart) II-60

Table 17: World 14-Year Perspective for HIV/AIDS Screening Tests by Geographic Region - Percentage Breakdown of Unit Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart) II-61

Table 18: World Recent Past, Current & Future Analysis for HIV/AIDS Confirmatory Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart) II-62

Table 19: World Historic Review for HIV/AIDS Confirmatory Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart) II-63

Table 20: World 14-Year Perspective for HIV/AIDS Confirmatory Tests by Geographic Region - Percentage Breakdown of Unit Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart) II-64 Dollar Analytics.............. II-65 Table 21: World Recent Past, Current & Future Analysis for HIV/AIDS Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart) II-65

Table 22: World Historic Review for HIV/AIDS Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).............. II-66

Table 23: World 14-Year Perspective for HIV/AIDS Testing by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015& 2020 (includes corresponding Graph/Chart) II-67 HIV/AIDS Testing by Test Type II-68 Table 24: World Recent Past, Current & Future Analysis for HIV/AIDS Screening Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America& Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart) II-68

Table 25: World Historic Review for HIV/AIDS Screening Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America & Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart) II-69

Table 26: World 14-Year Perspective for HIV/AIDS Screening Tests by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart) II-70

Table 27: World Recent Past, Current & Future Analysis for HIV/AIDS Confirmatory Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart) II-71

Table 28: World Historic Review for HIV/AIDS Confirmatory Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart) II-72

Table 29: World 14-Year Perspective for HIV/AIDS Confirmatory Tests by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)..............II-73

Table 30: World Recent Past, Current & Future Analysis for HIV/AIDS Monitoring Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart) II-74

Table 31: World Historic Review for HIV/AIDS Monitoring Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart) II-75

Table 32: World 14-Year Perspective for HIV/AIDS Monitoring Tests by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart) II-76

III. MARKET

1. THE UNITED STATES.............. III-1 A.Market Analysis.............. III-1 Outlook.............. III-1 Government Mandates and Reimbursement Policies Aid Market Growth.............. III-1 List of Key Milestones in HIV Testing & Reimbursement III-2 HIV Tests Available in the US Market III-2 Anti-HIV-2 Assay (to detect antibodies to Human Immunodeficiency Virus type 2) III-3 Anti-HIV-1/2 Assays (to detect antibodies to Human Immunodeficiency Virus types 1 and 2) III-4 FDA Approved HIV/AIDS Tests in the US Market: 2015 III-5 Competitive Structure..............III-5 Table 33: The US HIV POCT Market by Player (2014): Percentage Share of Sales for Chembio, OraSure Blood Tests, Orasure Saliva Tests, and Trinity (includes corresponding Graph/Chart).............. III-6 Rapid HIV Tests Gain Popularity III-6 FDA/USAID Approved HIV Rapid Test Kits (2014) III-6 Home HIV Tests Abate Privacy Concerns III-8 NAT Tests Score High in Blood Banks III-8 Major End-Users of HIV/AIDS Tests III-8 HIV Testing Made Mandatory in Blood Banks III-9 HIV/AIDS Statistics..............III-9 Table 34: Percentage of HIV/AIDS Cases in the US, by Gender: 1993-2029 (includes corresponding Graph/Chart) III-10

Table 35: AIDS Diagnoses in the US by Ethnic Group (Through 2013): Percentage Share of AIDS Diagnosis for Blacks, Asians, Hispanics, Native Hawaiian, Native/American Indians, Whites, and Multiple Races (includes corresponding Graph/Chart).............. III-11 Product Launches..............III-11 Strategic Corporate Developments III-13 Select Key Players..............III-14 B.Market Analytics..............III-18 Unit Analytics.............. III-18 Table 36: The US Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart).............. III-18

Table 37: The US Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart) III-19

Table 38: The US 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart).............. III-20 Dollar Analytics..............III-21 Table 39: The US Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)..............III-21

Table 40: The US Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).............. III-22

Table 41: The US 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart) III-23

2. CANADA.............. III-24 A.Market Analysis.............. III-24 Outlook.............. III-24 HIV Statistics.............. III-24 Table 42: Age Group Distribution of Reported HIV cases in Canada by Gender: 1985-2013 (includes corresponding Graph/Chart).............. III-24

Table 43: No. of Reported HIV Cases: 2005-2013 (includes corresponding Graph/Chart)..............III-25

Table 44: HIV Cases Reported in Canada by Ethnicity and Mode of Exposure (1998-2013): % Breakdown of Reported HIV cases Among different Ethnic Groups for Men who have sex with Men (MSM), Injection Drug Users (IDU), MSM/IDU, Heterosexuals, and Others (includes corresponding Graph/Chart).............. III-26

Table 45: HIV Diagnosis Rate in Canada by Province: 2013 (includes corresponding raph/Chart) III-27 Medmira Inc. - A Key Player..............III-27 B.Market Analytics..............III-28 Unit Analytics.............. III-28 Table 46: Canadian Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart).............. III-28

Table 47: Canadian Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart) III-29

Table 48: Canadian 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart).............. III-30 Dollar Analytics..............III-31 Table 49: Canadian Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart) III-31

Table 50: Canadian Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).............. III-32

Table 51: Canadian 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart) III-33

3. JAPAN.............. III-34 A.Market Analysis.............. III-34 Table 52: HIV Occurrence in Japan by Mode of Transmission (2014): Percentage Share of HIV Transmission by Homosexual Contact, Heterosexual contact, Congenital Transmission, Intravenous Drug use, Unknown Causes, and Others (includes corresponding Graph/Chart)..............III-34

Table 53: AIDS Occurrence in Japan by Mode of Transmission (2014): Percentage Share of AIDS Transmission by Homosexual Contact, Heterosexual contact, Intravenous Drug use, Unknown Causes, and Others (includes corresponding Graph/Chart) III-35 B.Market Analytics..............III-35 Unit Analytics.............. III-35 Table 54: Japanese Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart).............. III-35

Table 55: Japanese Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart) III-36

Table 56: Japanese 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart).............. III-37 Dollar Analytics..............III-38 Table 57: Japanese Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart) III-38

Table 58: Japanese Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).............. III-39

Table 59: Japanese 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart) III-40

4. EUROPE.............. III-41 A.Market Analysis.............. III-41 Outlook.............. III-41 Regional Analysis.............. III-41 Segment Analysis..............III-41 Aids/Hiv Stats - A Review..............III-41 Western Europe.............. III-41 Table 60: HIV/AIDS Prevalence in Western Europe: Facts and Figures by Country (2011) (includes corresponding Graph/Chart).............. III-42 Central Europe.............. III-43 Table 61: HIV/AIDS Prevalence in Central Europe: Facts and Figures by Country (2011) (includes corresponding Graph/Chart).............. III-43 Eastern Europe.............. III-44 Table 62: HIV/AIDS Prevalence in Eastern Europe: Facts and Figures by Country (2011) (includes corresponding Graph/Chart).............. III-44 Regulations.............. III-44 Antenatal HIV Testing in Europe III-44 B.Market Analytics..............III-45 Unit Analytics.............. III-45 Table 63: European Recent Past, Current & Future Analysis for HIV/AIDS Testing by Geographic Region - France, Germany, Italy, UK, Spain, & Rest of Europe Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart)..............III-45

Table 64: European Historic Review for HIV/AIDS Testing by Geographic Region - France, Germany, Italy, UK, Spain, & Rest of Europe Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart) III-46

Table 65: European 14-Year Perspective for HIV/AIDS Testing by Geographic Region - Percentage Breakdown of Unit Sales for France, Germany, Italy, UK, Spain, and Rest of Europe Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).............. III-47

Table 66: European Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart).............. III-48

Table 67: European Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart) III-49

Table 68: European 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart).............. III-50 Dollar Analytics..............III-51 Table 69: European Recent Past, Current & Future Analysis for HIV/AIDS Testing by Geographic Region - France, Germany, Italy, UK, Spain, & Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)..............III-51

Table 70: European Historic Review for HIV/AIDS Testing by Geographic Region - France, Germany, Italy, UK, Spain, & Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart) III-52

Table 71: European 14-Year Perspective for HIV/AIDS Testing by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, & Rest of Europe Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).............. III-53

Table 72: European Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart) III-54

Table 73: European Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).............. III-55

Table 74: European 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart) III-56

4a. FRANCE.............. III-57 A.Market Analysis.............. III-57 Pharmacies Start OTC Sales of HIV Home Testing Kits III-57 Product Launch.............. III-57 BioMérieux SA - A Key Player III-58 B.Market Analytics..............III-58 Unit Analytics.............. III-58 Table 75: French Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart).............. III-58

Table 76: French Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart) III-59

Table 77: French 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart).............. III-60 Dollar Analytics..............III-61 Table 78: French Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)..............III-61

Table 79: French Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).............. III-62

Table 80: French 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart) III-63

4b. GERMANY.............. III-64 Market Analysis.............. III-64 Unit Analytics.............. III-65 Table 81: German Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart).............. III-65

Table 82: German Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart) III-66

Table 83: German 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart).............. III-67 Dollar Analytics..............III-68 Table 84: German Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)..............III-68

Table 85: German Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).............. III-69

Table 86: German 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart) III-70

4c. ITALY.............. III-71 A.Market Analysis.............. III-71 Outlook.............. III-71 Table 87: HIV/AIDS Prevalence Rates by Age Group in Italy: End of 2011 (includes corresponding Graph/Chart) III-71 Product Launch.............. III-72 Key Player - Adaltis S.R.L...............III-72 B.Market Analytics..............III-73 Unit Analytics.............. III-73 Table 88: Italian Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart).............. III-73

Table 89: Italian Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart) III-74

Table 90: Italian 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart).............. III-75 Dollar Analytics..............III-76 Table 91: Italian Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart) III-76

Table 92: Italian Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).............. III-77

Table 93: Italian 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart) III-78

4d. THE UNITED KINGDOM..............III-79 A.Market Analysis.............. III-79 Outlook.............. III-79 HIV and AIDS Statistics..............III-79 Table 94: HIV Prevalence in the UK by Mode of Transmission (2013): Number of HIV Infections Estimated in MSM, People who Inject Drugs, and Heterosexuals (includes corresponding Graph/Chart).............. III-80

Table 95: HIV Prevalence in the UK in Heterosexuals (2013): Number of HIV Infections Estimated in Heterosexual Men and Women of African Ethnicity and Non-African Ethnicity (includes corresponding Graph/Chart) III-80

Table 96: New cases of HIV Diagnoses among Heterosexuals by Age Group (2013): Number of New HIV Infections in Heterosexuals of 15-24, 25-39, 40-49, & 50+ Age Groups (includes corresponding Graph/Chart) III-81 Product Launch.............. III-81 B.Market Analytics..............III-82 Unit Analytics.............. III-82 Table 97: The UK Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart).............. III-82

Table 98: The UK Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart) III-83

Table 99: The UK 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart).............. III-84 Dollar Analytics..............III-85 Table 100: The UK Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart) III-85

Table 101: The UK Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).............. III-86

Table 102: The UK 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart) III-87

4e. SPAIN.............. III-88 Market Analysis.............. III-88 Unit Analytics.............. III-88 Table 103: Spanish Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart).............. III-88

Table 104: Spanish Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart) III-89

Table 105: Spanish 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart).............. III-90 Dollar Analytics..............III-91 Table 106: Spanish Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart) III-91

Table 107: Spanish Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).............. III-92

Table 108: Spanish 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart) III-93

4f. REST OF EUROPE.............. III-94 A.Market Analysis.............. III-94 Outlook.............. III-94 Ukraine.............. III-94 Austria.............. III-94 Other European Countries..............III-94 Product Launches..............III-95 Strategic Corporate Developments III-95 Select Key Players..............III-96 B.Market Analytics..............III-97 Unit Analytics.............. III-97 Table 109: Rest of European Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart)..............III-97

Table 110: Rest of European Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart) III-98

Table 111: Rest of European 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)..............III-99 Dollar Analytics..............III-100 Table 112: Rest of European Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart) III-100

Table 113: Rest of European Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)..............III-101

Table 114: Rest of European 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart) III-102

5. ASIA-PACIFIC.............. III-103 A.Market Analysis.............. III-103 Outlook.............. III-103 The Next Epicenter for the AIDS Epidemic III-103 Table 115: AIDS/HIV Stats in Asia (2014) III-103 Review of Select Asian Countries III-103 Australia.............. III-103 Table 116: Number of HIV and AIDS Cases in Australia: 2005 to 2011 (includes corresponding Graph/Chart) III-104

Table 117: Number of AIDs Cases & Deaths in Australia by Age Group and Gender: End-2011 (includes corresponding Graph/Chart).............. III-105 China.............. III-105 AIDS/HIV - A Review..............III-105 Efforts to Combat HIV/AIDS III-106 India - HIV Concentrated in South and Northeast III-106 Table 118: Estimated Living Population in India with HIV/AIDS Infection (2009)..............III-106

Table 119: Prevalence of TB in HIV Patients In India (2010-2013): Total No. of People Attending HIV testing centres, Diagnosed TB cases, and the percentage of HIV-Positive TB patients started on ART (includes corresponding Graph/Chart) III-107 Thailand.............. III-107 HIV Cases on Decline..............III-107 Table 120: Number of Live Persons Infection with HIV in Thailand, by Category (2011-End): Percentage breakdown of Adult Men & Women, and Children with HIV Infection (includes corresponding Graph/Chart) III-108 Strategic Corporate Developments III-108 B.Market Analytics..............III-109 Unit Analytics.............. III-109 Table 121: Asia-Pacific Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart)..............III-109

Table 122: Asia-Pacific Historic Review for HIV/AIDS Testing by Test Type - HIV/ AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart) III-110

Table 123: Asia Pacific 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart).............. III-111 Dollar Analytics..............III-112 Table 124: Asia Pacific Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart) III-112

Table 125: Asia-Pacific Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)..............III-113

Table 126: Asia Pacific 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart) III-114

6. LATIN AMERICA.............. III-115 A.Market Analysis.............. III-115 Outlook.............. III-115 HIV Epidemic in Latin America..............III-115 Table 127: People Living with HIV Infection in Latin America by Country: 2011 (includes corresponding Graph/Chart).............. III-115 Trends and Transmission Modes..............III-116 Trends in Antiretroviral Treatment III-116 B.Market Analytics..............III-117 Unit Analytics.............. III-117 Table 128: Latin American Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart)..............III-117

Table 129: Latin American Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart) III-118

Table 130: Latin American 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart).............. III-119 Dollar Analytics..............III-120 Table 131: Latin American Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart) III-120

Table 132: Latin American Historic Review for HIV/AIDS Testing by Test Type - HIV/ AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)..............III-121

Table 133: Latin American 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart) III-122

7. REST OF WORLD.............. III-123 A.Market Analysis.............. III-123 Outlook.............. III-123 Africa: Epicenter of the HIV Epidemic III-123 Table 134: HIV/AIDS Cases in Africa as of 2011-End: Breakdown by Top 20 Countries (includes corresponding Graph/Chart).............. III-124

Table 135: Adults & Children Deaths Due to AIDS in Africa (2011): Breakdown by Top 10 Countries (includes corresponding Graph/Chart)..............III-125 Sub-Saharan Africa..............III-125 Table 136: AIDS/HIV Stats in Sub-Saharan Africa (2011) III-125 Southern Africa.............. III-125 East, West and Central Africa..............III-126 South Africa - The HIV/AIDS Hub III-126 Uganda - A Review.............. III-126 Caribbean Nations.............. III-126 Table 137: AIDS/HIV Stats in the Caribbean Nations (2011) III-127

Table 138: HIV/AIDS Prevalence in Caribbean Nations: 2014 (includes corresponding Graph/Chart) III-127 Strategic Corporate Developments III-128 B.Market Analytics..............III-129 Unit Analytics.............. III-129 Table 139: Rest of World Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart)..............III-129

Table 140: Rest of World Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart) III-130

Table 141: Rest of World 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart).............. III-131 Dollar Analytics..............III-132 Table 142: Rest of World Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart) III-132

Table 143: Rest of World Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)..............III-133

Table 144: Rest of World 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart) III-134

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 42 (including Divisions/Subsidiaries - 47)

The United States (33) Canada (2) Europe (8) - France (2) - Italy (2) - Rest of Europe (4) Asia-Pacific (Excluding Japan) (4)
Read the full report: http://www.reportlinker.com/p03449664-summary/view-report.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com


__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker



RELATED LINKS

http://www.reportlinker.com